GL1X · GenesisL1 explorer

Research workbench

Crystal structure of alpn-202 (engineered CD80 vigd) in complex with pd-L1

Analyse Crystal structure of alpn-202 (engineered CD80 vigd) in complex with pd-L1 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
7TPS
Type
protein
Length
621 residues
Chains
4
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
T-lymphocyte activation antigen CD80; Programmed cell death 1 ligand 1
UniProt
P33681, Q9NZQ7
Ligands
NAG, FUC
Pockets
6 · best druggability 0.72

Structure

x-ray diffraction · 3 distinct chains · 6% helix, 54% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AT-lymphocyte activation antigen CD80protein1068% helix, 56% strandP33681
B, DProgrammed cell death 1 ligand 1protein2096% helix, 55% strandQ9NZQ7
CT-lymphocyte activation antigen CD80protein973% helix, 51% strandP33681

Ligands and binding sites

  • NAG · 2-acetamido-2-deoxy-beta-D-glucopyranose · sugar · 14 copies · chains A, B, C, D
  • FUC · alpha-L-fucopyranose · sugar · 4 copies · chains B, D
  • GOL · Glycerol · additive · chains B, D

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

6 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12650.720.8647GOL
2620.380.7916empty
31080.360.7418empty
4720.340.7621empty
5570.270.7416empty

Interfaces

6 interfaces between chains.

  • B–D · 748 Ų buried · 14 hydrogen bonds · protein-protein
  • C–D · 571 Ų buried · 7 hydrogen bonds · protein-protein
  • A–B · 566 Ų buried · 11 hydrogen bonds · protein-protein
  • B–C · 42 Ų buried · 1 hydrogen bond · protein-protein
  • A–D · 39 Ų buried · 1 hydrogen bond · protein-protein

Modifications

Observed in the structure: 10 glycan, 6 disulfide, 1 modified (N-glycosylation, disulfide, phosphorylation).

Compared structures

  • 7TPS · Crystal structure of ALPN-202 (engineered CD80 vIgD) in complex with PD-L1 · the same entry in another collection · chain A against A, TM-score 1.00
  • P33681 · AlphaFold monomer V2.0 prediction for T-lymphocyte activation antigen CD80 (P33681) · a predicted model of the same protein · chain A against A, TM-score 0.96

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.